Sensitizing clinicians and patients to the social and functional aspects of remission

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 19, 2001, Pages 32-35

  Trivedi, M H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY NEUROSIS; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; MENTAL DISEASE; PANIC; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RATING SCALE; REMISSION; SOCIAL INTERACTION;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; QUALITY OF LIFE; REMISSION INDUCTION; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0034807657     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. A rating scale for depression
2. The assessment of anxiety states by rating
3. Introduction. Goal of antidepressant therapy: Response or remission and recovery?
4. Social functioning in depression: A review
5. Social adjustment and depression: A longitudinal study
6. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse
7. Evolution of remission as the new standard in the treatment of depression
8. Residual symptoms after partial remission: An important outcome in depression
9. Remission and relapse in subjects with panic disorder and panic with agoraphobia
10. Treatment of major depression: Is improvement enough?
11. The functioning and well-being of depressed patients: Results from the medical outcomes study
12. Quality of life in individuals with anxiety disorders
13. Quality of life and cost factors in panic disorder
14. Quality of life in patients with panic disorder
15. Panic disorder: Impact on quality of life
16. The impact of social phobia on quality of life
17. Changes in social functioning of depressive patients after treatment with venlafaxine and amitriptyline
18. Efficacy of venlafaxine ER in social adjustment in patients with generalized anxiety disorder
19. Why settle for silver, when you can go for gold? Response vs recovery as the goal of antidepressant therapy [BRAINSTORMS]
20. Treating depression to remission
21. The enhancement of social functioning as a therapeutic principle in the management of depression
22. Assessment of social adjustment by patient self-report
23. Social functioning and the treatment of depression
24. The assessment of social adjustment: A review of techniques
25. The assessment of social adjustment: An update
26. Development and validation of a social functioning scale: The social adaptation self-evaluation scale
27. Beyond symptoms: Social functioning and the new antidepressants